Aver Pharmaceuticals Private Limited, a active private limited company, was established on 21 May 2009 in Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232DL2009PTC190494. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Ashish Bhatia (Director), Sachin Bhatia (Director), Guneet Bhatia (Director). Past directors included Sachin Bhatia. It holds ₹3.70 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 355 3Rd Floor Blue Star Plaza Sarja Market Naharpur Rohini Sector 7, Delhi, Delhi, 110085.
U24232DL2009PTC190494
190494
21 May 2009
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Aver Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashish Bhatia | Director | 21 May 2009 | Current |
| Sachin Bhatia | Director | 21 May 2009 | Current |
| Guneet Bhatia | Director | 27 Feb 2014 | Current |
| Aman Dudeja | Director | 05 Dec 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Jan 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aver Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 67.33% decrease. The company also saw a substantial improvement in profitability, with a 25.8% increase in profit. The company's net worth moved up by a moderate rise of 5.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Aver Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,700,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Apr 2014 | Punjab National Bank | ₹3.70 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Aver Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aver Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aver Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aver Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Aver Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity Aman Dudeja was appointed as a Director was appointed as a Director on 05 Dec 2018 & has been associated with this company since 6 years 11 months . was completed.
A charge with Punjab National Bank amounted to Rs. 3.70 M with Charge ID 10494605 was registered on 22 Apr 2014. was recorded as a recent event.
Guneet Bhatia was appointed as a Director was appointed as a Director on 27 Feb 2014 & has been associated with this company since 11 years 9 months . was recorded as a recent event.
Progress on Ashish Bhatia was appointed as a Director was appointed as a Director on 21 May 2009 & has been associated with this company since 16 years 6 months . was documented.
The CIN of Aver Pharmaceuticals Private Limited is U24232DL2009PTC190494.
Aver Pharmaceuticals Private Limited is headquartered at 355 3Rd Floor Blue Star Plaza Sarja Market Naharpur Rohini Sector 7, Delhi, Delhi, 110085.
Aver Pharmaceuticals Private Limited was incorporated on 21 May 2009.
The current directors of Aver Pharmaceuticals Private Limited are
The primary industry of Aver Pharmaceuticals Private Limited is Pharma.
Aver Pharmaceuticals Private Limited is unlisted.
The authorized capital of Aver Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Aver Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX